Equity
Share Repurchase Authorization Limit
Vertex Pharmaceuticals Share Repurchase Authorization Limit decreased by 23.9% to $3.50B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 94.4%, from $1.80B to $3.50B. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalHigher is better
VolatilityModerate
First reportedQ3 2016
Last reportedQ3 2025
How to read this metric
An increase suggests management believes the stock is undervalued or that they have excess cash to return to investors.
Detailed definition
This is the total dollar amount approved by the board of directors for the company to buy back its own common stock from...
Peer comparison
Commonly disclosed by large-cap companies as part of their capital return strategy.
Metric ID:
share_repurchase_authorization_limitHistorical Data
9 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $2.90B | $2.80B | $2.70B | $2.40B | $2.10B | $1.80B | $964.40M | $4.60B | $3.50B |
| QoQ Change | — | -3.4% | -3.6% | -11.1% | -12.5% | -14.3% | -46.4% | +377.0% | -23.9% |
| YoY Change | — | — | — | -17.2% | -25.0% | -33.3% | -59.8% | +119.0% | +94.4% |
Range$964.40M – $4.60B
CAGR+9.9%
Avg YoY Growth+13.0%
Median YoY Growth-21.1%
Share Repurchase Authorization Limit at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's share repurchase authorization limit?
- Vertex Pharmaceuticals (VRTX) reported share repurchase authorization limit of $3.50B in Q3 2025.
- How has Vertex Pharmaceuticals's share repurchase authorization limit changed year-over-year?
- Vertex Pharmaceuticals's share repurchase authorization limit increased by 94.4% year-over-year, from $1.80B to $3.50B.
- What does share repurchase authorization limit mean?
- The maximum dollar amount the board has approved for buying back company shares.